Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Baclofen for Acute Spasticity After Traumatic SCI
NCT06564714Phase 4Not yet recruiting
- Start
- Dec 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of baclofen in spasticity (2 arms). Primary endpoints: Spinal Cord Independence Measure at 6 months and Adverse Events at 6 months. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
baclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT06564714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06564714.